Investor Relations

Investor Relations Overview
Corporate Profile

HC2 Holdings, Inc. is a publicly traded (NYSE: HCHC) diversified holding company, which seeks opportunities to acquire and grow businesses that can generate long-term sustainable free cash flow and attractive returns in order to maximize value for all stakeholders. HC2 has a diverse array of operating subsidiaries across eight reportable segments, including Construction, Marine Services, Energy, Telecommunications, Life Sciences, Broadcasting, Insurance and Other. HC2’s largest operating subsidiaries include DBM Global Inc., a family of companies providing fully integrated structural and steel construction services, and Global Marine Systems Limited, a leading provider of engineering and underwater services on submarine cables. Founded in 1994, HC2 is headquartered in New York, New York.

HC2 Company Overview

Recent NewsMore >>
DateTitle
06/13/19R2 Dermatology Announces Signing of Exclusive Asia-Pacific Distribution Agreement with China’s Huadong Medicine Company Limited
SAN RAMON, Calif., June 13, 2019 (GLOBE NEWSWIRE) -- R2 Dermatology (“R2”) announced today that it has entered into an exclusive distribution agreement with China’s Huadong Medicine Company Limited (“Huadong”) for the Asia-Pacific Region. In exchange, Huadong will make an equity investment in R2 Dermatology to fund R2’s next phase of product and market development.  “We are delighted to have found a superb strategic partner in Huadong and particularly excited to work with their entire team ... 
06/13/19Pansend Life Sciences’ Portfolio Company, R2 Dermatology, Enters Into Exclusive China/Asia-Pacific Distribution Agreement
R2 Dermatology Products to be Commercialized and Distributed by Huadong Medicine Company Limited NEW YORK, June 13, 2019 (GLOBE NEWSWIRE) -- HC2 Holdings, Inc. (“HC2”) (NYSE: HCHC), a diversified holding company, announced today that R2 Dermatology, a privately-held portfolio company within HC2’s Pansend Life Sciences (“Pansend”) subsidiary has entered into a strategic partnership agreement with Huadong Medicine Company Limited (“Huadong”) (SZ: 000963).  In exchange for an equity investment i... 
05/07/19DBM Global Inc., a HC2 Portfolio Company, to Pay Cash Dividend
NEW YORK, May 07, 2019 (GLOBE NEWSWIRE) -- HC2 Holdings, Inc. (NYSE:HCHC), a diversified holding company, announced today that its operating subsidiary DBM Global Inc. (OTC:DBMG), a family of companies providing fully integrated steel construction services, will pay a cash dividend of $15.0 million, or $3.89 per share, on May 29, 2019 to DBM Global Inc. stockholders of record at the close of business on May 17, 2019.  As the largest stockholder of DBM Global Inc., HC2 expects to receive approx... 
05/07/19HC2 Holdings Reports First Quarter 2019 Results
- First Quarter 2019 Consolidated Net Revenue Grew 8.3% Year-Over-Year to $491.4 Million - - Reaffirms 2019 Guidance for Construction Segment - NEW YORK, May 07, 2019 (GLOBE NEWSWIRE) -- HC2 Holdings, Inc. ("HC2" or the "Company") (NYSE: HCHC), a diversified holding company, announced today its consolidated results for the first quarter ended March 31, 2019. First Quarter 2019 Highlights Consolidated net revenue grew 8.3% year-over-year to $491.4 million. Net loss attributable to common and... 
04/23/19HC2 Holdings to Announce First Quarter 2019 Financial Results
NEW YORK, April 23, 2019 (GLOBE NEWSWIRE) -- HC2 Holdings, Inc. (NYSE:HCHC), a diversified holding company, announced today that it will release its financial results for the first quarter 2019 on Tuesday, May 7, 2019 after the market closes. The Company will host an earnings conference call reviewing these results and its operations the same day, beginning at 5:00 p.m. ET. Participating on the call will be Philip Falcone, Chairman, President and Chief Executive Officer, and Michael J. Sena... 
Upcoming EventsMore >>
There are currently no events scheduled.
Receive E-mail AlertsE-mail Alert Icon
Sign up to receive e-mail alerts whenever HC2 Holdings, Inc. posts new information to the site. Just enter your e-mail address and click Submit.
 
Data provided by Nasdaq. Minimum 15 minutes delayed.